MedPath

Erector Spinae Plane Block Versus Thoracic Paravertebral Block in Laparoscopic Cholecystectomy

Not Applicable
Not yet recruiting
Conditions
Pain, Acute Postoperative
Registration Number
NCT07149584
Lead Sponsor
Istanbul University
Brief Summary

The study is planned as a single-center prospective randomized study and includes patients undergoing laparoscopic cholecystectomy. The aim of this study is to compare postoperative analgesic efficacy of erector spinae plane block and thoracic paravertebral block. Primary outcome is 24-hour postoperative opioid consumption.

Detailed Description

All patients in the operating room receive the same anesthetic management under standard monitoring modalities. Both erector spinae plane block (ESPB) and thoracic paravertebral block (TPVB) are performed under ultrasound guidance at the T8 level using a linear probe and a longitudinal out-of-plane technique before induction of anesthesia. For ESPB, 10 mL of 0.375% bupivacaine is injected bilaterally between the deep fascia of the erector spinae muscle and the transverse process. For TPVB, 10 mL of 0.375% bupivacaine is injected bilaterally into the paravertebral space. After standard anesthesia induction, anesthesia is maintained with inhalation agents. Four milligrams of dexamethasone and 8 mg of ondansetron are administered for postoperative nausea and vomiting prophylaxis. As part of multimodal analgesia, all patients receive 1 g of paracetamol and 20 mg of tenoxicam.

All patients are followed according to a standardized postoperative analgesia protocol, which includes tramadol patient-controlled analgesia (10 mg bolus, 20-minute lockout). Postoperative static and dynamic pain scores are evaluated using the numeric rating scale (NRS) at 0, 1, 4, 6, 12, 18, and 24 hours. If the NRS score is greater than 3, 0.5 mg/kg meperidine is administered as rescue analgesia.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Elective cholecystectomy
  • Age >18years
  • American Society of Anesthesiologists classification I-III
Exclusion Criteria
  • Presence of contraindications for using regional anesthesia ( not having patient approval, bleeding diathesis or use of anticoagulants, infection at the injection site, and allergy to local anesthetics)
  • Chronic analgesic use
  • Open cholecystectomy or conversion to open cholecystectomy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Tramadol consumptionpostoperative 24 hours

amount of postoperative 24-hour tramadol consumption

Secondary Outcome Measures
NameTimeMethod
Amount of fentanylduring surgery

Amount of fentanyl used intraoperatively

Static and dynamic pain scorepostoperative 24 hours

Static and dynamic pain scores are assessed with numeric rating scale at 0., 1., 4., 6., 12., 18. and 24. hours.

First rescue analgesic timepostoperative 24 hours

The first time patient required rescue analgesic.

Number of patients required rescue analgesic.postoperative 24 hours

If the NRS score is greater than 3, 0.5 mg/kg meperidine is administered as rescue analgesia.

Nausea and vomitingpostoperative 24 hours

Number of patients experienced postoperative nausea and vomiting

Complicationspostoperative 24 hours

Number of patients experienced complications postoperatively

Quality of recoverypostoperative 24 hours

Patient recovery quality is evaluated using the Quality of Recovery-15 (QoR-15) questionnaire. QoR-15 scores range from 0 (extremely poor quality of recovery) to 150 (excellent quality of recovery).

Length of hospital stayup to 1 week

Length of hospital stay

Trial Locations

Locations (1)

Istanbul University, Istanbul Faculty of Medicine

Istanbul, Turkey (Türkiye)

Istanbul University, Istanbul Faculty of Medicine
Istanbul, Turkey (Türkiye)
Özlem Turhan
Contact
00902124142000
ozlemturhan6@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.